Status: Recruiting
IVIG vs SCIG in CIDP
Current dosing practices for immunoglobulin G (IgG) may be inadequate in extreme body weight. The current study will evaluate the influence of body composition on intravenous and subcutaneous administration of immunoglobulin G in patients.
Participants needed: 20
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Rutgers, The State University of New JerseyUpdated: Dec 11, 2025Locations: 1
Eligibility criteria
Patients aged >18 years with a current diagnosis of CIDP (based on European Fede... [+1]
Patients receiving IVIG for indications other than CIDP will be excluded. [+6]